MR guidance of targeted injections into border and core of scarred myocardium in pigs

Radiology

Volumn 240, Issue 2, 2006, Pages 419-426

  Saeed, Maythem ^a   Martin, Alastair J ^a   Lee, Randall J ^b   Weber, Oliver ^a   Revel, Didier ^a   Saloner, David ^a   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYSPROSIUM; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; IRON OXIDE; NONIONIC CONTRAST MEDIUM; SPRODIAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATHETER; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; FLUOROSCOPY; HEART INFARCTION; HEART LEFT VENTRICLE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGE RECONSTRUCTION; INJECTION SITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCAR FORMATION; SIGNAL DETECTION; SPHAERIALES; STEADY STATE; SWINE;

ANIMALS; CONTRAST MEDIA; IMAGE ENHANCEMENT; INJECTIONS; MAGNETIC RESONANCE IMAGING; MEGLUMINE; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; PHANTOMS, IMAGING; SWINE;

EID: 33746220377     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2402051086     Document Type: Article

References (31)

1. Kajstura J, Leri A, Finato N, et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A 1998;95:8801-8805.
2. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-280.
3. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final 1-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004;44:1690-1699.
4. Britten MB, Abolmaali ND, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI). Circulation 2003;108:2212-2218.
5. Fuchs S, Satler LF, Kornowski R, et al. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 2003;41:1721-1724.
6. Laham RJ, Rezaee M, Post M, et al. Intramyocardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 2000;292:795-802.
7. Laham RJ, Rezaee M, Post M, et al. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. Drug Metab Dispos 1999;27:821-826.
8. Inoue M, Ito H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998;98:2108-2116.
9. Saeed M, Saloner D, Weber O, et al. MRI in guiding and assessing intramyocardial therapy. Eur Radiol 2005;15:851-863.
10. Lee RJ, Springer ML, Blanco-Bose, Shaw R, Ursell P, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102:898-901.
11. Rezaee M, Yeung AC, Altman P, et al. Evaluation of the percutaneous intramyocardial injection for local myocardial treatment. Catheter Cardiovasc Interv 2001;53:271-276.
12. Sanborn TA, Hackett NR, Lee LY, et al. Percutaneous endocardial transfer and expression of genes to the myocardium utilizing fluoroscopic guidance. Catheter Cardiovasc Interv 2001;52:260-266.
13. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37:1726-1732.
14. Kornowski R, Hong M, Gepstein L, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 1998;98:1116-1124.
15. Saeed M, Lee RJ, Martin A, et al. Transendocardial delivery of extracellular myocardial markers by using combination x-ray/MR fluoroscopic guidance: feasibility study in dogs. Radiology 2004;231(3):689-696.
16. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
17. Saeed M, Wendland MF, Watzinger M, et al. MR contrast media for myocardial viability, microvascular integrity and perfusion. Eur J Radiol 2000;34:179-195.
18. Krombach GA, Baireuther R, Higgins CB, Saeed M. Distribution of intramyocardially injected extracellular MR contrast, medium: effects of concentration and volume. Eur Radiol 2004;14:334-340.
19. Krombach GA, Pfeffer JG, Kinzel S, Katoh M, Guenther RW, Buecker A. MR-guided percutaneous intramyocardial injection with an MR-compatible catheter: feasibility and changes in T1 values after injection of extracellular contrast medium in pigs. Radiology 2005;235:487-494.
20. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003;107:2290-2293.
21. Hill JM, Dick AJ, Raman VK, et al. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003;108:1009-1014.
22. Dick AJ, Guttman MA, Raman VK, et al. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 2003;108:2899-2904.
23. Karmarkar PV, Kraitchman DL, Izbudak I, et al. MR-trackable intramyocardial injection catheter. Magn Reson Med 2004;51:1163-1172.
24. Saeed M, Wendland MF, Yu KK, Higgins CB. The utility of optimal dose of dysprosium-DTPA-BMA in the delineation of acute myocardial infarction. J Am Coll Cardiol 1992;20:1634-1641.
25. Sakuma H, O'Sullivan M, Lucas J, et al. Effect of magnetic susceptibility contrast medium on myocardial signal intensity with fast gradient-recalled echo and spin-echo MR imaging: initial experience in humans. Radiology 1994;190:161-166.
26. Ni Y, Pislaru C, Bosmans H, et al. Intracoronary delivery of Gd-DTPA and Gadophrin-2 for determination of myocardial viability with MR imaging. Eur Radiol 2001;11:876-883.
27. Martin AJ, Weber OM, Saeed M, Roberts TP. Steady-state imaging for visualization of endovascular interventions. Magn Reson Med 2003;50:434-438.
28. Lewin JS, Duerk JL, Jain VR, et al. Needle localization in MR-guided biopsy and aspiration: effect of field strength, sequence design and magnetic field orientation. AJR Am J Roentgenol 1996;166:1337-1345.
29. Vale PR, Losordo DW, Milliken CE, et al. Left ventricular electromechanical mapping to ass efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 2000;102:965-974.
30. Nitz WR, Oppelt A, Renz W, Manke C, Lenhart M, Link J. On the heating of linear conductive structures as guidewires and catheters in interventional MRI. J Magn Reson Imaging 2001;13:105-114.
31. Yeung CJ, Susil RC, Atalar E. RF heating due to conductive wires during MRI depends on the phase distribution of the transmit field. Magn Reson Med 2002;48:1096-1098.